TrialFind
Saved trials
Back to results
Completed
Phase 4
Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria
NCT00320879
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Steno Diabetes Center
Gentofte Municipality, Copenhagen, Denmark
View on ClinicalTrials.gov
Official details
Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria — TrialFind